Clinical Diagnostics Technology & Disease Research News | 360Dx
WEBQiagen Targets Oncohematology, Companion Diagnostics Space With Clinical Digital PCR Instrument. The firm launched the QiAcuityDx system on Monday and will seek US Food and Drug Administration 510 (k) clearance along with a BCR-ABL assay. The authors of a commentary said they view recent study results as informative, though limited, regarding ...
About Us - 360Dx
WEBAbout Us. 360Dx is published by GenomeWeb, an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and diagnostics. GenomeWeb is a family brand of Crain ...
Healgen Gains FDA Marketing Authorization for OTC COVID, Flu …
WEB13 hours ago · NEW YORK – The US Food and Drug Administration said on Monday that it has granted marketing authorization for Healgen Scientific's home-use combination test for flu and COVID-19. While the agency has previously granted Emergency Use Authorizations for multiple home-use combination tests, Healgen's Rapid Check COVID-19/Flu A&B Antigen Test is ...
Top Five Articles on 360Dx Last Week: Roche’s New PCR …
WEB1 day ago · NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: 1) Roche Leveraging New PCR Technology for 12-Target Respiratory Test 2) FDA Clears Abionic Point-of-Care Sepsis Test https 3) As Digital Pathology Slowly Expands, Industry Anxiously Awaits a Breakout Moment 4) Owlstone Medical, FDA to Develop Breath-Based Disease Detection ...
Gradientech Wins Hardy Diagnostics as Investor, North American ...
WEB6 hours ago · NEW YORK – Gradientech said on Tuesday that Hardy Diagnostics will distribute its QuickMIC antibiotic susceptibility testing system in the US and Canada and is becoming an investor of the Swedish company. Hardy Diagnostics will invest an undisclosed amount in Uppsala-based Gradientech …
Lumos Diagnostics Sets Stage for US Expansion With New …
WEB3 days ago · NEW YORK –With nearly $10 million in recent contracts and financing, and new distribution agreements in place, Australian infectious disease company Lumos Diagnostics hopes to obtain CLIA waiver for its FebriDx rapid host-response test next year to catalyze its US expansion. This week, Lumos announced a $3 …
Coronavirus Test Tracker: Commercially Available COVID-19 ... - 360Dx
WEBAs labs and diagnostic developers race to meet demand for assays to detect the SARS-CoV-2 coronavirus, 360Dx is updating this tracker on a regular basis in order to provide readers with up-to-date and accurate information on the regulatory status of these tests in the US, European, and Asian markets. The tracker includes only those tests that ...
With COVID-19 Response Evolving, Next-Gen Dx Technologies …
WEBSep 22, 2022 · NEW YORK – The COVID-19 pandemic drove massive amounts of public and private investment into the diagnostics industry as the US and world saw unprecedented demand for testing.
360Dx Top 30 Slides 1 Percent in January
WEBFeb 1, 2024 · 360Dx Top 30 Slides 1 Percent in January. Note: The 360Dx Top 30 has been updated with new entries Biodesix, MDxHealth, OraSure Technologies, and Sera Prognostics based on market cap as of beginning of trading in January 2024. LumiraDx was removed due to the acquisition of most of its assets by Roche, and Accelerate Diagnostics, Burning Rock ...
Harvard Researchers Develop AI-Based Model for Cancer Dx, …
WEBSep 6, 2024 · NEW YORK – Researchers from Harvard Medical School have developed a new artificial intelligence-based model for systematically diagnosing multiple cancer types and predicting patients' prognoses from digital pathology images. Described in a paper published this week in Nature, the Clinical Histopathology …